Tower Research Capital LLC (Trc) Fibrogen Inc Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.89 - $2.36 $3,022 - $8,014	-3,396 Reduced 16.04%	17,773 $15,000
Q1 2024 May 15, 2024	BUY	$0.73 - $2.73 $5,340 - $19,972	7,316 Added 52.81%	21,169 $49,000
Q4 2023 Feb 13, 2024	BUY	$0.38 - $0.91 $684 - $1,638	1,800 Added 14.93%	13,853 $12,000
Q3 2023 Nov 14, 2023	SELL	$0.79 - $2.83 $5,545 - $19,863	-7,019 Reduced 36.8%	12,053 $10,000
Q2 2023 Aug 14, 2023	BUY	$2.49 - $20.59 $39,060 - $322,995	15,687 Added 463.43%	19,072 $51,000
Q1 2023 May 09, 2023	BUY	$15.95 - $25.18 $37,689 - $59,500	2,363 Added 231.21%	3,385 $63,000
Q4 2022 Feb 10, 2023	SELL	$13.27 - $17.73 $172,244 - $230,135	-12,980 Reduced 92.7%	1,022 $16,000
Q3 2022 Nov 10, 2022	SELL	$11.4 - $14.6 $7,558 - $9,679	-663 Reduced 4.52%	14,002 $182,000
Q2 2022 Aug 15, 2022	BUY	$7.94 - $12.96 $23,446 - $38,270	2,953 Added 25.21%	14,665 $155,000
Q1 2022 May 12, 2022	BUY	$12.02 - $16.79 $12,705 - $17,747	1,057 Added 9.92%	11,712 $140,000
Q4 2021 Feb 14, 2022	SELL	$9.93 - $15.39 $23,921 - $37,074	-2,409 Reduced 18.44%	10,655 $151,000
Q3 2021 Nov 15, 2021	BUY	$10.18 - $26.64 $72,430 - $189,543	7,115 Added 119.6%	13,064 $134,000
Q2 2021 Aug 16, 2021	SELL	$18.57 - $35.68 $80,649 - $154,958	-4,343 Reduced 42.2%	5,949 $159,000
Q1 2021 May 17, 2021	BUY	$31.0 - $55.72 $159,681 - $287,013	5,151 Added 100.19%	10,292 $357,000
Q4 2020 Feb 16, 2021	SELL	$37.09 - $48.97 $74,550 - $98,429	-2,010 Reduced 28.11%	5,141 $191,000
Q3 2020 Nov 16, 2020	SELL	$40.47 - $45.5 $148,160 - $166,575	-3,661 Reduced 33.86%	7,151 $294,000
Q2 2020 Aug 13, 2020	BUY	$32.57 - $42.83 $352,146 - $463,077	10,812 New	10,812 $438,000
Q1 2020 May 15, 2020	SELL	$23.3 - $45.96 $137,446 - $271,118	-5,899 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$34.58 - $48.06 $203,987 - $283,505	5,899 New	5,899 $253,000
Q3 2019 Nov 05, 2019	SELL	$36.98 - $48.45 $1,627 - $2,131	-44 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$35.13 - $55.53 $21,921 - $34,650	-624 Reduced 93.41%	44 $2,000
Q1 2019 May 14, 2019	BUY	$42.83 - $59.91 $24,798 - $34,687	579 Added 650.56%	668 $36,000
Q4 2018 Feb 14, 2019	SELL	$37.97 - $60.16 $23,731 - $37,600	-625 Reduced 87.54%	89 $4,000
Q3 2018 Nov 13, 2018	BUY	$56.3 - $67.25 $40,198 - $48,016	714 New	714 $43,000
Q1 2018 May 15, 2018	SELL	$45.35 - $61.65 $8,299 - $11,281	-183 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$41.95 - $60.1 $183,615 - $263,057	-4,377 Reduced 95.99%	183 $9,000
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $152,304 - $245,784	4,560	4,560 $245,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account